Correlation between maternal and cord blood leptin and fetal growth by Rafeey, M et al.
African Journal of Biotechnology Vol. 6 (17), pp. 2023-2027, 5 September 2007 
Available online at http://www.academicjournals.org/AJB 
ISSN 1684–5315 © 2007 Academic Journals 
 
 
 
 
Full Length Research Paper 
 
Correlation between maternal and cord blood leptin 
and fetal growth 
 
Rafeey, M1*, Ouladsahebmadarek, E2, Rashtchizadeh, N3, Sheikh Monazah, F4, 
Gorbanihaghjo, A5, Hosseini, MB6, and Nejati, N7. 
 
1Liver and Gastrointestinal Diseases Research Center -Drug Applied Research Center (DARC), Tabriz University of 
Medical Sciences, Tabriz, Iran. 
2Obstetrics and Gynecology Department, Tabriz University of Medical Sciences, Tabriz, Iran. 
3Biochemistry Department, Drug Applied Research Center (DARC) -Biotechnology Research Center, Tabriz, Iran. 
4General physician, Tabriz University of Medical Sciences, Tabriz, Iran. 
5Biochemistry Department, Drug Applied Research Center (DARC) -Biotechnology Research Center, Tabriz, Iran. 
6Neonatology Department, Tabriz University of Medical Sciences, Tabriz, Iran. 
7Pediatrics Department, Tabriz University of Medical Sciences, Tabriz, Iran. 
 
Accepted 7 August, 2007 
 
Leptin is a protein secreted mainly by the adipocyte in proportion to fat mass. The serum leptin 
concentration reflects the amount of adipose tissue in the body and has potential role on the fat 
deposition in the fetus. In the present study, we investigated whether umbilical and maternal serum 
leptin concentrations correlate with fetal growth. In addition, we determined the relationship between 
leptin concentration in the maternal and cord blood. We studied 100 newborn infants (48 female and 52 
male; gestational age, 34 - 40 weeks) and their mothers at Alzahra hospital in Tabriz city. Serum leptin 
concentrations were measured by ELISA and linear regression analysis was used to evaluate 
correlation. In the results, there was no significant correlation between umbilical and maternal leptin 
concentrations (r = 0.011; p = 0.459) in all study groups. There was a correlation between umbilical 
leptin concentration and birth weight of newborns (r = 0.278; p = 0.003) and correlation with body mass 
index (BMI) of the newborns (r = 0.249; p = 0.006). Maternal leptin concentrations correlated with 
maternal weight and BMI (r = 0.277; p = 0.003, r = 0.290; p = 0.002, respectively). There was no 
correlation between maternal leptin concentrations and birth weight (r = - 0.162; p = 0.054) and with BMI 
of the newborns (r = - 0.158; p = 0.058). There was gender difference in leptin concentrations in the 
newborns (r = 0.331; p = 0.00025) with greater level in females. In conclusion, we have shown that the 
association between umbilical serum leptin and birth weight in this and other studies suggests a pivotal 
role of fetal leptin in regulating fetal growth and development. 
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INTRODUCTION 
 
Leptin is 16 kDa protein encoded by the ob gene and 
produced by adipocytes (Halaas et al., 1995). The con-
centration of serum leptin is high in obese adults and low 
in lean adults (Maffei et al., 1995; Considine et al., 1996). 
Leptin signals the amount of fat stored in the body to the 
brain and  affects  food  intake,  energy  expenditure,  and  
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thermogenesis to maintain a constant amount of stored 
body fat (Hassink et al., 1996). However, the physiolo-
gical role of leptin in growing children has not been 
clarified.  
Modeling of human leptin (Green et al., 1995) indicate 
that the molecule is a globular protein with a tertiary 
structure similar to that of helical cytokines, which include 
IL -2 and growth hormone. The long form of the leptin 
receptor functions similarly to cytokine receptors and has 
been detected in the human lung, kidney, liver and 
skeletal muscle, as well  as  the  heart,  placenta,  spleen, 
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Table 1. Clinical and Para clinical features of 100 infants were included in the 
study. 
 
Parameter Value 
Mean gestational age (week) 38.5±1.60 
Mean birth weight (gr) 3133.7±467.4 
Height (cm) 48.34±2.15 
Head circumference (cm) 34.69±1.25 
BMI (kg/m2) 13.4±1.83 
Sex  %52 (male), %48 (Female) 
Mean maternal age (years) 25.36±4.85 
Cesarean section 30.9% 
Neonatal gestational age range (week) 34-40 weeks 
Neonatal birthweight range (g) 2020-4920 g 
Neonate leptin levels range (ng/ml) 11.5± 8.33 ng/ml 
Mothers leptin levels  (ng/ml) 25.45±17.59 ng/ml 
Mean 5-min APGAR Scores 8.88±0.65 
 
 
 
thymus, prostate, testis, ovary, small intestine, and colon 
(Green  et al.  1995). The finding of leptin receptors in 
numerous tissues supports the hypothesis that leptin is 
important for growth and development (Schubring et al., 
1999; Schubring et al., 1997). 
A series of epidemiological, clinical and experimental 
studies have shown that there are associations between 
the fetal and neonatal nutritional environment and the 
amount and distribution of adipose tissue in adult life. The 
potential impact of the prenatal nutritional experience on 
the development of the endocrine and neuroendocrine 
systems is to regulate energy balance, with a particular 
emphasis on the role of the adipocyte-derived hormone, 
leptin. In the rodent, leptin derived from the mother may 
exert an important influence on the development of the 
appetite regulatory neural network and on the subsequent 
regulation of leptin synthesis and the risk for obesity in 
the offspring. In species such as the human and sheep, 
there is also recent evidence that the synthesis and 
secretion of adipocyte-derived hormones, such as leptin, 
are regulated in fetal life (Bouret et al., 2004; Kratzsch et 
al., 2005). 
The role of leptin among the complex network of factors 
controlling fetal growth is incompletely understood. Leptin 
is positively associated with birth weight, but the mecha-
nism(s) underlying this association remains unknown. 
This association may reflect either a simple relationship 
with adipose tissue mass or an active role for leptin in 
fetal growth. Fat deposition in the fetus in the third 
trimester increases markedly. The mechanism of adiposi-
ty and physiological roles of leptin in the fetus have yet to 
be elucidated. In the present study, whether or not the 
concentration of serum leptin correlates with growth in 
utero was investigated. 
A majority of leptin research in humans has so far 
focused on adults. In a recent preliminary report, leptin 
was detectable in cord blood at birth, and it correlated 
with birth weight (Schubring et al., 1999; Schubring et al.,   
1999). The present study was undertaken to examine 
further how different intrauterine growth patterns relate to 
leptin secretion in utero. In addition, no data exists about 
potential roles for leptin during gestation. In fact, during 
late pregnancy, leptin could be one of the links between 
the neuroendocrine system and the adipose tissue, which 
expands during pregnancy. Therefore, we tested whether 
leptin is present in human cord blood at birth. In addition, 
we measured leptin in maternal serum at term and 
analyzed whether there are correlations between mater-
nal and cord leptin concentrations and growth parameters 
in fetus at birth. 
 
 
MATERIALS AND METHODS 
 
One hundred healthy mothers who gave birth to healthy newborns 
at Alzahra University Teaching Hospital from December 2005 were 
randomly enrolled in the study. Informed consent was obtained 
from all mothers. Approval of the study protocol by the Ethical 
Committee of Tabriz University had been taken before the study 
started. Clinical and auxological data (Table 1) were obtained by 
one investigator and recorded using a standardized data sheet. 
After that 5 ml maternal and 5 ml umbilical vein blood samples were 
obtained directly after birth.  
Neonates with dismorphic features, major congenital malforma-
tions, intrauterine infections, organic disorders, or chromosomal 
disorders were excluded. Mother who had diabetes mellitus (MD) 
(gestational DM, non insulin-dependent DM, insulin-dependent DM) 
was excluded. The infants were divided into term (n = 80) and 
preterm groups (n = 20). Infants were divided into 3 subgroups: birth 
weight appropriate for gestational age (AGA) (n = 96), birth weight 
large for gestational age (LGA) (n = 2), and birth weight small for 
gestational age (SGA) (n =2) according to the Lubchenco chart. 
Gestational ages were determined from the last menstrual period of 
the mother and confirmed by antenatal ultrasonic measurement of 
the biparietal diameter. The Ponderal Index was used for nutritional 
assessment of the neonate. The Ponderal Index was calculated as 
follows: Ponderal Index = body weight (g)/[body length (cm)]3 x 100. 
Placental weight directly after  birth was measured. 
 
 
 
 
Table 2. Correlation between the leptin concentration in cord blood 
with fetal growth factors. 
 
Parameter r P - Value 
Maternal age -0.131 0.098 
*Gestational age (sonography) 0.2 0.023* 
Gestational age (LMP) 0.144 0.07 
Increments of maternal weight 0.098 0.169 
Maternal BMI 0.056 0.290 
Maternal weight 0.093 0.180 
Maternal height 0.099 0.162 
Neonate Birth weight  0.278 0.003* 
*Neonate Birth height 0.190 0.029* 
*Neonate gender 0.331 <0.00025* 
Birth kind 0.069 0.255 
Head circumference 0.037 0.356 
Chest 0.085 0.199 
Belly -0.006 0.476 
Arm index -0.061 0.274 
APGAR score 0.070 0.244 
*Placental weight 0.574 P<0.00025* 
Ponderal Index 0.088 0.193 
*Neonate fat mass percent 0.178 0.038* 
*Neonate – BMI 0.249 0.006* 
Maternal leptin 0.011 0.459 
 
r : Correlation; *: Significant correlation. 
 
 
 
Blood sampling and examination of serum concentration of 
leptin 
 
A blood sample from the umbilical vein was obtained after double 
clamping of the umbilical cord immediately after birth. Venous blood 
of mothers were obtained after delivery from antecubital vein for 
study of serum leptin levels and were stored at 4oC for a maximum 
of 12 h. They were then centrifuged, and serum was aliquot and 
stored at -70oC until assayed. The serum leptin concentration was 
determined by DRG Instruments GmbH, DRG diagnostic, Marburg, 
Germany, 2395. The coefficient values of inter- and intraassays 
were 4.2 and 3.8%, respectively. The detection limit was 0.5 ng/mL.  
 
 
Statistical analysis  
 
Differences between groups were tested using the Mann-Whitney 
test for unrelated samples and the Wilcoxon test for paired samples. 
Linear regression analysis was used to evaluate correlation. 
Variance analysis was used to determine significant differences 
among the groups and P<0.05 considered significant.  
 
 
RESULTS 
 
100 infants were included in the study (mean gestational 
age, 38.5 ± 1.60 weeks). Mean birth weight was 3133.7 ±  
467.4 g, height was 48.34 ± 2.15 cm, head circumference 
was 34.69 ± 1.25 cm, and body mass index (BMI) was 
13.4 ±1.83 kg/m2. Fifthy-two percent of studied subjects 
were male. Mean maternal age was 25.36 ± 4.85 yr, and  
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cesarean section was made of delivery in 30.9% of 
mothers. The clinical data were summarized in Table 1. 
The neonatal gestational ages ranged from 34 to 40 
weeks with neonatal birth weights ranging from 2020 g to 
4920 g. Serum leptin levels were measured in the 100 
mother/neonate pairs, and all samples had detectable 
leptin levels. In the neonates, leptin cord blood levels 
ranged from 11.50 ± 8.33 0 ng/ml. For the mothers, the 
range was 25.45±17.59 ng/ml. The mean, 5 min Apgar 
scores was 8.88 ± 0.65 in newborns. 
There was no meaningful difference in maternal serum 
leptin concentrations delivering female or male infants (r 
= 0.057; P= 0.288), but we found significant correlation 
between cord leptin concentration and gender of infants 
(r = 0.331; P<0.00025), so female infants had greater 
level of cord blood leptin (9.49 ± 8.23 ng/ml in males 
versus 13.67±7.96 ng/ml in females). Cord blood leptin 
concentrations correlated closely with birth weights (r = 
0.278; P = 0.003), with height ((r = 0.19; P < 0.029) , with 
placental weight (r = 0.574; P = 0.00025). 
Mean leptin concentrations in maternal serum at birth 
were 25.45± 17.59 ng/ml (range=2.9-89; median=19.9). 
Although, maternal leptin serum levels were higher than 
cord blood levels, there was no significant correlation 
between them (r = 0.011; p = 0.459). There was a 
significant correlation between leptin levels in umbilical 
vein and birth weight of the neonates (r = 0. 278, P < 
0.003). Maternal BMI at the beginning of pregnancy and 
maternal body weights at the end of pregnancy were 
correlated with leptin levels in maternal serum at term (r = 
0.290, p = 0.002 and r = 0.277; p = 0.003). Placental 
weight correlated inversely with leptin levels in maternal 
serum at birth (r = -0.084, P = 0.202) although this 
correlated with leptin level in cord blood (r = 0.574; p = 
0.00025). 
When stepwise regression analysis and ANOVA was 
used to determine whether placental weight or birth 
weight contributed more to the relation between leptin 
levels and auxological data, both placental weight and of 
birth weight remained dependent on each other. A similar 
and dependent contribution of placental weight and birth 
weight in respect to leptin concentrations was suggested 
by comparable P values in the ANOVA (P < 0.003) for 
both placental weight and birth weight. There was no 
relation between leptin levels in cord blood and APGAR 
score at 5 min after delivery (r = 0.070; p = 0.244) (Table 
2). There were no significant correlations between 
maternal serum leptin levels and neonatal birth weights (r 
= -0.162, p = 0.054) but there was correlation with 
neonatal gestational ages at birth with LMP method (r = -
0.211, p= 0.0003) and sonography (r = 0.211 p=0.018) 
(Table 3). Cord blood leptin levels were correlated with 
neither maternal body weights nor maternal body mass 
index at birth (r = 0.093, p = 0.180, r = 0.056, p = 0.290; 
respectively).  
  The clinical data are summarized in Table 1. There was 
no correlation between  leptin  levels  in  maternal  serum 
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Table 3. Correlation between the leptin concentrations in maternal 
blood with fetal growth factors. 
 
Parameter r P - Value 
Maternal age -0.94 0.177 
*Gestational age (sonography) -0.211 0.018* 
Gestational age (LMP) -0.270 0.003* 
Increments of maternal weight (kg) 0.152 0.067 
Maternal BMI 0.290 0.002* 
Maternal weight 0.277 0.003* 
Maternal height -0.022 0.414 
Neonate Birth weight  -0.162 0.054 
*Neonate Birth height -0.054 0.297 
*Neonate gender -0.057 0.288 
Birth kind 0.119 0.127 
Head circumference -0.180 0.036* 
Chest -0.133 0.093 
Belly -0.175 0.041* 
Arm index -0.101 0.158 
APGAR score -0.62 0.270 
*Placental weight -0.084 0.202 
Ponderal Index -0.164 0.052 
* Neonate fat mass percent -0.126 0.105 
* Neonate –BMI -0.158 0.058 
Maternal leptin 0.011 0.459 
 
r : Correlation; *: Significant correlation. 
 
 
 
and umbilical cord serum (r = 0.11, p = 0.459). We 
observed highly significant correlations between umbilical 
serum leptin levels and both neonatal birth weights (r = 
0.278, p<0.003) and gestational ages at birth (r = 0.2, p = 
0.023) (Table 2). We also found correlation between cord 
leptin and neonatal fat mass (r = 0.178, p = 0.038).  
 
 
DISCUSSION 
 
Our study showed that leptin levels were less in umbilical 
cord serum than in maternal serum and this study 
suggests that leptin of fetus is produced by itself or by 
placenta. In intrauterine fetal growth, Hassink et al. 
(1997) reported the synthesis of leptin in the placenta, 
and that the leptin concentration in cord blood correlates 
with newborn anthropometry. In addition, umbilical serum 
leptin levels were found to correlate positively with 
neonatal birth weights. Therefore, fetal leptin levels may 
be involved in fetal development during late pregnancy. 
These results suggest that rapidly growing fetal adipose 
tissue is a major contributory factor. It has been shown 
that, after 32 weeks of gestation, fetal growth occurs via 
cellular hypertrophy, and that most fetal fat and glycogen 
deposition takes place during this phase (Jaquet et al., 
1998; Hoggard et al., 2001; Schubring et al. 1998). Given 
the above observations, we hypothesize that during late 
gestation, fetal leptin may stimulate fetal growth. The pre-  
 
 
 
 
sence of leptin in human cord blood has been reported by 
several investigators (Schubring et al., 1999). Koistinen 
et al. (1997) found a positive association of leptin 
concentration in cord blood with intrauterine growth. 
Matsuda et al. (1997) found serum leptin concentration in 
cord blood to be correlated positively with BW (r = 0.555; 
P < 0.001) in the study of 82 newborns ranging in 
gestational age from 36 weeks to 42 weeks and in BW 
from 2306 to 4128 g (Matsuda et al., 1997). A similar 
correlation (r = 0.57; P = 0.03) between leptin concen-
tration in cord blood and BW was reported by Schubring 
et al. (1997) who noted a positive association between 
cord blood leptin concentration and placental weight 
(r = .50; P < .01). Our study showed positive correlation 
between cord blood leptin concentration and placental 
weight (r = 0.574; p = 0.00025) too. 
Umbilical serum leptin levels were also found to corre-
late positively with neonatal gestational ages at birth. This 
suggests that the increased umbilical serum leptin levels 
associated with advancing gestational age are a conse-
quence of increased fetal body weight. Also we observed 
that maternal serum leptin levels were correlated with 
maternal body weights, body mass index at delivery and 
gestational age but that there was no correlation with 
neonatal birth weights. It seems that maternal serum 
leptin levels may only be a marker for maternal fat mass, 
but do not play a major role in fetal growth. In contrast, 
BMI at delivery and maternal weight did not correlate with 
leptin levels in maternal serum in Schubring et al. (1997). 
It is unclear what specific regulators of leptin levels might 
be effective during gestation and at term. These data 
might simply reflect the poor correlation of BMI and 
weight measurements with fat tissue expansion during 
pregnancy. However, a more perfect study design may 
be warranted, which would allow us to be more 
conclusive. 
Hormonal regulation of leptin levels in the fetus and 
neonate might be different from the endocrine modulation 
of leptin levels seen throughout adult life; whereas insulin 
and glucocorticoids (Sinha et al., 1996; Rentsch and 
Chiesi, 1996) are thought to modulate leptin levels 
throughout adult life, this might not be entirely relevant for 
the fetus and neonate. There was no sex difference of 
leptin levels in cord blood at term reported by Shekhawat 
et al. (1998) and Shekhawat et al.  (2000). This is in 
contrast to the situation in the adult where consistently 
higher levels of leptin are found in serum from females 
than from males (Considine et al., 1996; MacDougald et 
al., 1995). One possible explanation for the absence of a 
gender difference of leptin levels at birth might be that the 
body fat mass of a neonate is not gender specific. 
In summary, our study showed that leptin levels were 
higher in maternal serum than umbilical cord serum 
(11.5±8.33 vs 25.45±17.59). In addition, umbilical serum 
leptin levels were found to correlate positively with 
neonatal birth weights. Therefore, fetal leptin levels may 
be involved in fetal development  during  late  pregnancy. 
 
 
 
 
Our data indicate that birth weight is dependently asso-
ciated with leptin concentrations in cord blood of 
newborns. This suggests that leptin may be involved in 
as-yet-unknown mechanisms that regulate fetal growth. 
Additional studies will likely lead to an understanding of 
the mechanism(s) by which leptin may regulate fetal 
growth. 
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